Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$27.44 - $35.56 $1.38 Million - $1.78 Million
50,136 Added 112.25%
94,800 $2.78 Million
Q4 2023

Feb 08, 2024

BUY
$28.47 - $38.49 $665,600 - $899,857
23,379 Added 109.84%
44,664 $1.62 Million
Q3 2023

Oct 31, 2023

BUY
$28.28 - $38.36 $601,939 - $816,492
21,285 New
21,285 $683,000
Q3 2022

Nov 14, 2022

SELL
$28.84 - $38.92 $469,024 - $632,955
-16,263 Reduced 48.99%
16,934 $515,000
Q2 2022

Aug 15, 2022

BUY
$33.25 - $45.11 $34,048 - $46,192
1,024 Added 3.18%
33,197 $1.24 Million
Q1 2022

May 12, 2022

SELL
$40.68 - $49.72 $824,298 - $1.01 Million
-20,263 Reduced 38.64%
32,173 $1.46 Million
Q4 2021

Feb 10, 2022

SELL
$43.21 - $57.6 $7,691 - $10,252
-178 Reduced 0.34%
52,436 $2.53 Million
Q3 2021

Nov 10, 2021

SELL
$52.8 - $60.32 $30,676 - $35,045
-581 Reduced 1.09%
52,614 $2.93 Million
Q2 2021

Aug 11, 2021

SELL
$51.29 - $59.15 $368,980 - $425,525
-7,194 Reduced 11.91%
53,195 $2.89 Million
Q1 2021

May 12, 2021

BUY
$42.18 - $56.07 $20,583 - $27,362
488 Added 0.81%
60,389 $3.39 Million
Q4 2020

Feb 10, 2021

SELL
$35.18 - $43.52 $64,801 - $80,163
-1,842 Reduced 2.98%
59,901 $2.61 Million
Q3 2020

Nov 13, 2020

BUY
$37.98 - $48.72 $922,913 - $1.18 Million
24,300 Added 64.9%
61,743 $2.4 Million
Q2 2020

Aug 12, 2020

BUY
$31.07 - $44.74 $1.04 Million - $1.49 Million
33,390 Added 823.83%
37,443 $1.62 Million
Q1 2020

May 14, 2020

SELL
$22.46 - $42.24 $1.73 Million - $3.26 Million
-77,136 Reduced 95.01%
4,053 $134,000
Q4 2019

Feb 12, 2020

BUY
$39.01 - $47.51 $359,867 - $438,279
9,225 Added 12.82%
81,189 $3.36 Million
Q3 2019

Nov 12, 2019

SELL
$38.66 - $47.41 $811,009 - $994,566
-20,978 Reduced 22.57%
71,964 $3.29 Million
Q2 2019

Aug 09, 2019

BUY
$38.23 - $47.43 $1.88 Million - $2.34 Million
49,290 Added 112.92%
92,942 $4.01 Million
Q1 2019

May 15, 2019

BUY
$41.26 - $58.35 $1.35 Million - $1.91 Million
32,714 Added 299.09%
43,652 $1.9 Million
Q4 2018

Feb 14, 2019

BUY
$44.93 - $73.38 $150,964 - $246,556
3,360 Added 44.34%
10,938 $517,000
Q3 2018

Nov 13, 2018

BUY
$56.85 - $80.35 $201,192 - $284,358
3,539 Added 87.62%
7,578 $565,000
Q4 2017

Feb 14, 2018

SELL
$28.0 - $33.2 $368,172 - $436,546
-13,149 Reduced 76.5%
4,039 $113,000
Q3 2017

Nov 14, 2017

BUY
$24.5 - $31.1 $421,106 - $534,546
17,188
17,188 $533,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $477M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.